Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Vitam Nutr Res ; 90(3-4): 309-317, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30987549

RESUMO

Aim of this work was to determine the effects of dietary intake vitamin E and Se on lipid peroxidation (LPO) as Thiobarbituric acid reactive substances (TBARS) and on the antioxidative defense mechanisms in heart tissues of rats treated with high doses of prednisolone. 250 adult male Wistar rats were randomly divided into 5 groups and fed with normal diet. Additionally groups 3, 4, and 5 received a daily supplement in their drinking water of 20 mg vitamin E, 0.3 mg Se, and a combination of vitamin E and Se (20 mg/ 0.3 mg), respectively, for 30 days. For 3 d subsequently, control group was treated with placebo, and remaining four groups were injected intramuscularly with 100 mg/kg prednisolone. After last administration of prednisolone, 10 rats from each group were killed at 4, 8, 12, 24, and 48 h and the activities of antioxidant enzymes and the levels of GSH and TBARS were measured. GSH-Px, CAT activities and GSH levels decreased starting from 4th hour to 48% and 65% of control levels by 24th hour, respectively and it reincreased to control levels at 48th hour in the prednisolone group (p < 0.001, p < 0.001). In addition, prednisolone administration led 2-fold increase in heart TBARS levels at 24th hour (p < 0.001). E vitamins and Se inhibited the increase in heart TBARS and the decrease in antioxidative enzymes levels. Therefore, It is concluded that vitamin E and Se may have a preventive role in decreasing the increase of TBARS caused by prednisolone administration in our study.


Assuntos
Glutationa Peroxidase , Peroxidação de Lipídeos , Fígado , Prednisolona , Selênio , Vitamina E , Animais , Masculino , Ratos , Antioxidantes/farmacologia , Glutationa Peroxidase/química , Glutationa Peroxidase/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/química , Fígado/metabolismo , Estresse Oxidativo/fisiologia , Prednisolona/farmacologia , Prednisolona/toxicidade , Ratos Wistar , Selênio/uso terapêutico , Substâncias Reativas com Ácido Tiobarbitúrico , Vitamina E/metabolismo , Vitamina E/uso terapêutico
2.
Acta Cir Bras ; 34(3): e201900305, 2019 Mar 18.
Artigo em Inglês | MEDLINE | ID: mdl-30892391

RESUMO

PURPOSE: To investigate the effects of the EtOAc extract of U. longissima which is uninvestigated previously on esophagogastric cancer induced in rats with N-methyl-N-nitro-N-nitrosoguanidin (MNNG). METHODS: The anticancer activity of EtOAc extract of U. longissima was examined in the esophagogastric adenocarcinoma models induced in rats with MNNG. EtOAc extract of U. longissima, 50 and 100 mg/kg oral doses were administered once daily for six months. MNNG induced differentiated and undifferentiated type adenocarcinomas in the esophageal and gastric tissues of rats. RESULTS: EtOAc extract of U. longissima obtained from U. longissima prevented gastric and esophageal cancerogenesis induced in rats with MNNG. EtOAc extract of U. longissima did not have a lethal effect at doses of 500, 1000 and 2000 mg/kg. The prominent anticarcinogenic activity of EtOAc extract of U. longissima 50 and 100 mg/kg suggests that it is not toxic and it is selective to the cancer tissue. CONCLUSION: This information may shed light on clinical implementation of EtOAc extract of U. longissima in future.


Assuntos
Acetatos/uso terapêutico , Adenocarcinoma/tratamento farmacológico , Antineoplásicos Fitogênicos/uso terapêutico , Extratos Vegetais/uso terapêutico , Neoplasias Gástricas/tratamento farmacológico , Usnea/química , Animais , Masculino , Neoplasias Experimentais/tratamento farmacológico , Ratos , Ratos Wistar
3.
Acta cir. bras ; 34(3): e201900305, 2019. graf
Artigo em Inglês | LILACS | ID: biblio-989062

RESUMO

Abstract Purpose: To investigate the effects of the EtOAc extract of U. longissima which is uninvestigated previously on esophagogastric cancer induced in rats with N-methyl-N-nitro-N-nitrosoguanidin (MNNG). Methods: The anticancer activity of EtOAc extract of U. longissima was examined in the esophagogastric adenocarcinoma models induced in rats with MNNG. EtOAc extract of U. longissima, 50 and 100 mg/kg oral doses were administered once daily for six months. MNNG induced differentiated and undifferentiated type adenocarcinomas in the esophageal and gastric tissues of rats. Results: EtOAc extract of U. longissima obtained from U. longissima prevented gastric and esophageal cancerogenesis induced in rats with MNNG. EtOAc extract of U. longissima did not have a lethal effect at doses of 500, 1000 and 2000 mg/kg. The prominent anticarcinogenic activity of EtOAc extract of U. longissima 50 and 100 mg/kg suggests that it is not toxic and it is selective to the cancer tissue. Conclusion: This information may shed light on clinical implementation of EtOAc extract of U. longissima in future.


Assuntos
Animais , Masculino , Ratos , Neoplasias Gástricas/tratamento farmacológico , Extratos Vegetais/uso terapêutico , Adenocarcinoma/tratamento farmacológico , Usnea/química , Acetatos/uso terapêutico , Antineoplásicos Fitogênicos/uso terapêutico , Ratos Wistar , Neoplasias Experimentais/tratamento farmacológico
4.
J Appl Oral Sci ; 24(5): 423-430, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27812611

RESUMO

OBJECTIVE:: To investigate the effect of HRE (Hippophae rhamnoides extract) on oral mucositis induced in rats with MTX. MATERIAL AND METHODS:: Experimental animals were divided into groups as healthy (HG), HRE+MTX (HMTX), and control group, which received MTX (MTXC). HMTX group received 50 mg/kg HRE while MTXC and HG groups received equivolume distilled water with gavage once a day. After one hour of HRE and distilled water administration, HMTX and MTXC groups received a single dose of oral MTX 5 mg/ kg. This procedure was repeated for one month. RESULTS:: The levels of MDA, IL-1ß, and TNF-α were found to be significantly higher in the cheek, lower lip, and tongue tissue of the animals receiving MTX, compared with HG and HMTX groups; however, these parameters were lower in the cheek and low lip tissue, and a milder damage ocurred in these tissues, compared with the tongue tissue in MTXC group. No histopathologic damage was observed in the cheek, lower lip, and tongue tissues of the rats treated with HRE. CONCLUSION:: This findings indicate that HRE as a natural product is an important advantage compared with synthetic drugs for prophylaxis of oral mucositis developed due to MTX.


Assuntos
Antagonistas do Ácido Fólico/efeitos adversos , Hippophae/química , Metotrexato/efeitos adversos , Extratos Vegetais/farmacologia , Estomatite/induzido quimicamente , Estomatite/tratamento farmacológico , Animais , Vasos Sanguíneos/patologia , Bochecha/patologia , Expressão Gênica , Interleucina-1beta/análise , Interleucina-1beta/efeitos dos fármacos , Lábio/patologia , Malondialdeído/análise , Extratos Vegetais/uso terapêutico , Ratos , Reprodutibilidade dos Testes , Estomatite/patologia , Língua/patologia , Resultado do Tratamento , Fator de Necrose Tumoral alfa/análise , Fator de Necrose Tumoral alfa/efeitos dos fármacos
5.
J. appl. oral sci ; 24(5): 423-430, Sept.-Oct. 2016. graf
Artigo em Inglês | LILACS, BBO | ID: lil-797985

RESUMO

ABSTRACT Objective: To investigate the effect of HRE (Hippophae rhamnoides extract) on oral mucositis induced in rats with MTX. Material and Methods: Experimental animals were divided into groups as healthy (HG), HRE+MTX (HMTX), and control group, which received MTX (MTXC). HMTX group received 50 mg/kg HRE while MTXC and HG groups received equivolume distilled water with gavage once a day. After one hour of HRE and distilled water administration, HMTX and MTXC groups received a single dose of oral MTX 5 mg/ kg. This procedure was repeated for one month. Results: The levels of MDA, IL-1β, and TNF-α were found to be significantly higher in the cheek, lower lip, and tongue tissue of the animals receiving MTX, compared with HG and HMTX groups; however, these parameters were lower in the cheek and low lip tissue, and a milder damage ocurred in these tissues, compared with the tongue tissue in MTXC group. No histopathologic damage was observed in the cheek, lower lip, and tongue tissues of the rats treated with HRE. Conclusion: This findings indicate that HRE as a natural product is an important advantage compared with synthetic drugs for prophylaxis of oral mucositis developed due to MTX.


Assuntos
Animais , Ratos , Estomatite/induzido quimicamente , Estomatite/tratamento farmacológico , Extratos Vegetais/farmacologia , Metotrexato/efeitos adversos , Hippophae/química , Antagonistas do Ácido Fólico/efeitos adversos , Estomatite/patologia , Língua/patologia , Vasos Sanguíneos/patologia , Extratos Vegetais/uso terapêutico , Expressão Gênica , Bochecha/patologia , Reprodutibilidade dos Testes , Fator de Necrose Tumoral alfa/análise , Fator de Necrose Tumoral alfa/efeitos dos fármacos , Resultado do Tratamento , Interleucina-1beta/análise , Interleucina-1beta/efeitos dos fármacos , Lábio/patologia , Malondialdeído/análise
6.
Cutan Ocul Toxicol ; 35(3): 222-7, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26339826

RESUMO

CONTEXT: Ethambutol-induced retinal oxidative damage in patients with tuberculosis is still not being adequately treated. The protective effect of thiamine pyrophosphate against oxidative damage in some tissues has been reported, but no information on the protective effects of thiamine pyrophosphate against ethambutol-induced oxidative retinal damage has been found in the medical literature. OBJECTIVE: The objective is to investigate whether thiamine pyrophosphate has a protective effect against oxidative retinal damage in rats induced by ethambutol. MATERIALS AND METHODS: Experimental animals divided into four groups (n = 10): the healthy group (HG), the ethambutol control group (EMB), thiamine + ethambutol group (Thi-EMB) and thiamine pyrophosphate + ethambutol group (TPP-EMB). The rats in the TPP-EMB and Thi-EMB groups were administered thiamine pyrophosphate and thiamine, respectively, at doses of 20 mg/kg intraperitoneally. Distilled water was administered intraperitoneally to the HG and the EMB groups as a solvent in the same volumes. One hour after drug injection, 30 mg/kg ethambutol was administered via an oral gavage to the TPP-EMB, Thi-EMB and EMB groups. This procedure was repeated once a day for 90 days. At the end of this period, all rats were euthanized under high-dose thiopental sodium anesthesia, and biochemical and histopathological investigations of the retinal tissue were performed. RESULTS: Malondialdehyde (MDA) and DNA damage product 8-hydroxyguanine levels were significantly lower in the retinal tissue of TPP-EMB and HG groups compared to those of the Thi-EMB and EMB groups, and total glutathione (tGSH) was also found to be higher. In addition, severe retinal tissue vascularization, edema and loss of ganglion cells were observed in the Thi-EMB and EMB groups, whereas histopathological findings for the TPP-EMB group were observed to be close to normal. DISCUSSION AND CONCLUSION: These findings suggest that thiamine pyrophosphate protects retinal tissues from ethambutol-induced oxidative damage, and thiamine does not. This positive effect of thiamine pyrophosphate may be useful in the prevention of ocular toxicity that occurs during ethambutol use.


Assuntos
Antioxidantes/uso terapêutico , Antituberculosos/efeitos adversos , Etambutol/efeitos adversos , Oftalmopatias/induzido quimicamente , Oftalmopatias/tratamento farmacológico , Tiamina Pirofosfato/uso terapêutico , Animais , Antioxidantes/farmacologia , Dano ao DNA , Olho/efeitos dos fármacos , Olho/metabolismo , Olho/patologia , Oftalmopatias/metabolismo , Oftalmopatias/patologia , Glutationa/metabolismo , Guanina/análogos & derivados , Guanina/metabolismo , Masculino , Malondialdeído/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ratos Wistar , Tiamina/farmacologia , Tiamina/uso terapêutico , Tiamina Pirofosfato/farmacologia
7.
Life Sci ; 130: 31-7, 2015 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-25818190

RESUMO

AIMS: This study investigates the effect of a new combination of glucosamine hydrochloride, chondroitin sulfate, methylsulfonylmethane, Harpagophytum procumbens root extract (standardized to 3% harpagoside) and bromelain extract (GCMHB) on formalin-induced damage to cartilage tissue in the rat knee joint and evaluates this combination in comparison with another combination of glucosamine hydrochloride, chondroitin sulfate and methylsulfonylmethane (GKM). MATERIALS AND METHODS: Animals in the control group were injected with formalin into the knee joint (FCG). Animals in the GCMHB-500 group were given 500mg/kg GCMHB+formalin, and those in the GKM-500 group were given 500mg/kg GKM+formalin. Finally, a healthy group (HG) was also used. GCMHB and GKM were administered to rats orally once a day for 30days. At the end of this period, the rats were sacrificed and the levels of MDA, NO, 8-OH/Gua, and tGSH in the knee joint tissue were measured. Analysis of IL-1ß and TNF-α gene expression was done and the tissue was evaluated histopathologically. KEY FINDINGS: MDA, NO and 8-OH/Gua levels and IL-1ß and TNF-α gene expression were significantly lower in the GCMHB-500 group compared to the FCG group, whereas tGSH was significantly higher in the GCMHB-500 group than in the FCG group. No significant difference was found for the IL-1ß, TNF-α and oxidant/antioxidant parameters between the GKM and FCG groups. The histopathological analysis showed that GCMHB could prevent damage to the cartilage joint, whereas GKM could not. SIGNIFICANCE: GCMHB may be used clinically by comparing with GKM in the treatment of osteoarthritis.


Assuntos
Bromelaínas/farmacologia , Sulfatos de Condroitina/farmacologia , Dimetil Sulfóxido/farmacologia , Glucosamina/farmacologia , Harpagophytum/química , Sulfonas/farmacologia , Animais , Bromelaínas/administração & dosagem , Cartilagem/efeitos dos fármacos , Cartilagem/patologia , Sulfatos de Condroitina/administração & dosagem , Dimetil Sulfóxido/administração & dosagem , Modelos Animais de Doenças , Combinação de Medicamentos , Formaldeído/toxicidade , Regulação da Expressão Gênica/efeitos dos fármacos , Glucosamina/administração & dosagem , Interleucina-1beta/genética , Articulação do Joelho/efeitos dos fármacos , Articulação do Joelho/patologia , Masculino , Osteoartrite/tratamento farmacológico , Extratos Vegetais/administração & dosagem , Extratos Vegetais/farmacologia , Ratos , Ratos Wistar , Sulfonas/administração & dosagem , Fator de Necrose Tumoral alfa/genética
8.
Med Sci Monit ; 18(12): BR475-81, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23197226

RESUMO

BACKGROUND: Oxidative liver injury occurring with methotrexate restricts its use in the desired dose. Therefore, whether or not thiamine and thiamine pyrophosphate, whose antioxidant activity is known, have protective effects on oxidative liver injury generated with methotrexate was comparatively researched in rats using biochemical and histopathological approaches. MATERIAL/METHODS: Thiamine pyrophosphate+methotrexate, thiamine+methotrexate, and methotrexate were injected intraperitoneally in rats for 7 days. After this period, all animals' livers were excised, killing them with high-dose anesthesia, and histopathologic and biochemical investigations were made. RESULT: Biochemical results demonstrated a significant elevation in level of oxidant parameters such as MDA and MPO, and a reduction in antioxidant parameters such as GSH and SOD in the liver tissue of the methotrexate group. Also, the quantity of 8-OHdG/dG, a DNA injury product, was higher in the methotrexate group with high oxidant levels and low antioxidant levels, and the quantity of 8-OHdG/dG was in the thiamine pyrophosphate group with low oxidant levels and high antioxidant levels. In the thiamine and control groups, the 8-OHdG/dG rate was 1.48 ± 0.35 pmol/L (P>0.05) and 0.55 ± 0.1 pmol/L (P<0.0001). Thiamine pyrophosphate significantly decreased blood AST, ALT and LDH, but methotrexate and thiamine did not decrease the blood levels of AST, ALT and LDH. Histopathologically, although centrilobular necrosis, apoptotic bodies and inflammation were monitored in the methotrexate group, the findings in the thiamine pyrophosphate group were almost the same as in the control group. CONCLUSIONS: Thiamine pyrophosphate was found to be effective in methotrexate hepatotoxicity, but thiamine was ineffective.


Assuntos
Fígado/metabolismo , Fígado/patologia , Metotrexato/efeitos adversos , Estresse Oxidativo/efeitos dos fármacos , Tiamina Pirofosfato/farmacologia , Tiamina/farmacologia , 8-Hidroxi-2'-Desoxiguanosina , Alanina Transaminase/metabolismo , Animais , Aspartato Aminotransferases/metabolismo , Desoxiguanosina/análogos & derivados , Desoxiguanosina/metabolismo , Glutationa/metabolismo , L-Lactato Desidrogenase/metabolismo , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Malondialdeído/metabolismo , Peroxidase/metabolismo , Ratos , Ratos Wistar , Superóxido Dismutase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA